ImmuPharma plc (FRA:25I)

Germany flag Germany · Delayed Price · Currency is EUR
0.0590
0.00 (0.00%)
At close: Dec 5, 2025
490.00%
Market Cap 36.73M
Revenue (ttm) n/a
Net Income (ttm) -4.59M
Shares Out n/a
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 56
Open 0.0590
Previous Close 0.0590
Day's Range 0.0590 - 0.0590
52-Week Range 0.0005 - 0.2180
Beta n/a
RSI 40.17
Earnings Date May 18, 2026

About ImmuPharma

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom. Its peptide-based therapeutics focuses on autoimmunity and inflammation, and anti-infectives therapeutic areas. The company’s lead product candidate includes P140, a peptide technology platform, which is in Phase III clinical trial that targets autoimmune diseases for systemic lupus erythematosus; P140, which is in Phase II clinical trial for the treatment of chronic inflammatory demyelinating polyneuropathy, a rare acquired aut... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1999
Employees 6
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 25I
Full Company Profile

Financial Performance

Financial numbers in GBP Financial Statements

News

There is no news available yet.